Fortitude Family Office, LLC
Family OfficePosition in ESPR — Esperion Therapeutics, Inc.
CIK 1950506
SCOTTSDALE, AZ
Position in ESPR
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$767
+$767 QoQ
Shares Held
243
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 40 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Fortitude Family Office, LLC holds $231,944 across 21 Drug Manufacturers - Specialty & Generic names. ESPR ranks #17 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
2,964 | $47,068 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
64 | $34,677 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
174 | $29,325 | |
| 4 | LQDA |
Liquidia Corp
|
327 | $26,071 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
637 | $22,084 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
249 | $15,923 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
800 | $13,848 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,500 | $11,880 |
All Filings in ESPR
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $767 | 243 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | — | 243 | Shares | Sole | 2026-04-16 | |
| No filing history on record for this holder in this stock. | ||||||